Breast cancer remains the most prevalent cancer among women worldwide, driving the
urgent need for innovative approaches to diagnosis and treatment. This review highlights …

Biological variability poses significant challenges in the development of effective
therapeutics, particularly when it comes to drug solubility and bioavailability. Poor solubility …

Advanced nanotechniques and the corresponding complex nanostructures they produce
represent some of the most powerful tools for developing novel drug delivery systems …

Cancer stem cells (CSCs) present a formidable challenge in cancer treatment due to their
inherent resistance to chemotherapy, primarily driven by the overexpression of ABC …

Purpose Improving the treatment of triple-negative breast cancer (TNBC) is a serious
challenge today. The primary objective of this study was to construct MUC1-C shRNA …

In recent years, significant progress has been made in the surface functionalization of
magnetic nanoparticles (MNPs), revolutionizing their utility in multimodal imaging, drug …

Drug delivery plays a crucial part in medical therapy, where stimuli-responsive nanocarriers
exhibit high delivery efficacy through changing their physicochemical properties in response …

Cancer immunotherapy has emerged as a novel therapeutic approach against tumors, with
immune checkpoint inhibitors (ICIs) making significant clinical practice. The traditional ICIs …

The glioblastoma stem cell (GSC) population in glioblastoma multiforme (GBM) poses major
complication in clinical oncology owing to increased resistance to chemotherapeutic drugs …

Brain metastasis and primary glioblastoma multiforme represent the most common and
lethal malignant brain tumors. Its median survival time is typically less than a year after …